This map is a guide for Montreal startup founders to all the active VCs across Montreal. If you're a VC looking to be on the list, or would like to adjust your profile (logo, description, location, etc.) kindly msg Michael on LinkedIn.
We are BDC, the bank for Canadian entrepreneurs. Our mission is to help create and develop strong Canadian businesses through financing, consulting services and securitization, with a focus on small and medium-sized enterprises. Through our subsidiary—BDC Capital, we also offer a full spectrum of specialized financing, including venture capital, equity as well as growth and business transition capital.
Panache Ventures is Canada's most active seed stage venture capital fund. Panache is led by a team of experienced operators, with a strong angel investor track record, years of institutional VC experience and a strong network in Canada, in Silicon Valley and worldwide. The fund has a founders-first philosophy, a commitment to diversity and strategically coinvests with smart angel investors and seed stage funds.
linkedin.comInovia Capital is a venture capital firm that partners with founders to build impactful and enduring global companies. The team leverages an operator-led mindset to provide founders with multi-stage support, mentorship, and access to a worldwide network. Inovia manages over US$2.5B with operations in Montreal, Toronto, Waterloo, Calgary, and London.
Brightspark Capital is the venture capital firm behind every single investment. Leveraging our network, our reputation, and lessons learned over 25 years in the industry, we invest in some of Canada's top emerging tech companies.
Diagram is a venture builder that conceives and launches technology companies in the financial services, insurance, and health industries. We've designed a unique platform for entrepreneurs who have a proven track record or domain expertise to start their next business by combining access to venture capital investment, hands-on support, and a vast network of partners and incumbents. Since 2016, Diagram has raised over $145M and launched eleven new companies across North America. Our ecosystem is home to 90+ angel investors, including 45+ entrepreneurs with >$15B in exits and an extended global network of corporate partners, investors, and builders.
White Star Capital is an international multi-stage technology investment manager built by a team of founders, investors and operators with a track record of entering new markets, expanding teams and exiting companies.
BCF Ventures is a Canadian Corporate Venture Capital (CVC) Fund investing at the seed/seed+ stage of technology-based startups mostly in the United States and Canada, and opportunistically in Europe/Israel.
NAventures is the corporate venture capital arm of National Bank of Canada, one of Canada’s largest and most trusted financial institutions.
Real Ventures is an early-stage venture firm focused on serving daring entrepreneurs with the ambition to create successful, global companies. Since 2007, Real Ventures has dedicated itself to building the Canadian startup ecosystem on the belief that people, not money, build game-changing companies. Real Ventures provides stage-specific guidance, mentorship, and access to networks and resources to fast-track founders’ personal and company growth. Real Ventures manages $325 million across five funds and its active portfolio of 100+ companies is currently valued at $10 billion.
Framework was founded in 2018 and has set the benchmark for active capital investing for early-stage companies. Framework combines a unique, data-driven model with a high-touch collaborative engagement approach designed to assist Founders and CEOs in high-growth markets to scale while becoming better, smarter and more prepared for the next phase of growth.
Pender Ventures is a thesis-driven venture capital investor focused on B2B software and health tech startups at the inflection point between commercialization and scale. As hands-on, high-conviction investors, Pender Ventures’ diverse team leverages decades of experience to add operational and strategic value to its portfolio companies.
BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Highline Beta is a hybrid corporate venture studio and VC firm that evolves the traditional management consulting model to put things into action, not just strategize in the clouds.
The Holt Xchange is Canada's most active seed fintech investor. Supported through five generations of experience and a robust global network, Holt Xchange is powering innovative tech products, world-class companies, and entrepreneurs, helping shape the future of their businesses and technology in the financial services sector.
Cycle Capital is a leading private ClimateTech venture capital investment platform with offices in Montreal and Toronto, and a presence in the U.S., Europe and Asia. Cycle Capital invests across North America, Europe and Asia in growing and commercializing companies that have developed technologies that positively contribute to climate change mitigation by enabling a net-zero transition, reducing greenhouse gas emissions, and optimizing resources and processes.
Lumira Ventures is a leading healthcare and life sciences venture capital firm, investing in innovative entrepreneurs developing best and first-in-class therapeutics & medical technologies across North America. We are engaged partners who support the management teams of companies we invest in to build products that have the potential to allow people to lead fundamentally healthier, longer, and more productive lives.
Theodorus invests in early stage companies based on proprietary disruptive technologies, leading financing rounds from inception to Series A and above.
Portage is a global investment platform focused on fintech and financial services. Our team partners with ambitious companies across all stages, providing flexible capital and deliver a global network of investors, commercial partners, advisors and value creation experts. With deep industry knowledge and entrepreneurial experience, Portage is committed to supporting the leaders who are reshaping financial services.
Luge Capital is a fintech-focused venture capital firm that invests in early-stage companies in Canada and the United States. We’re on a mission to build fintech champions with amazing founders.
Teralys Capital is a technology-focused Fund of funds which finances private venture capital funds investing in life sciences, information technology and cleantech companies. With more than $2.5 billion in assets under management across four recent venture capital fund-of-funds, Teralys is the largest innovation focused investor in Canada with aggregate exposure to more than 80 funds and 1,500 companies.
Accelia Capital is a venture capital fund that invests in innovative companies with high technological potential. We aim for diversity, performance, and impact by fostering businesses owned or led by women.
Amplify Capital is the evolution of the MaRS Catalyst Fund, investing in mission-driven, double-bottom-line disruptors in health, education and cleantech. Every dollar invested in these companies generates a financial return and a social return. That’s how we amplify capital. And we further amplify our impact by encouraging partners, investors and co-investors to invest in companies where purpose drives profit. As investors, what we invest in today shapes the world of tomorrow.
AQC Capital invests in entrepreneurs with innovative technology companies at the pre-seed and seed stages who are looking to disrupt a global market.
Founded in 2021, BKR Capital (formerly Black Innovation Capital) was built with the objective of investing in promising black founders in the technology space.
The Ecofuel Fund is a venture capital fund specialized in the financing of innovative start-ups in the clean technology sector. The Ecofuel Fund contributes to sustainable development by supporting businesses in Quebec, Ontario and the Maritimes with the collaboration of its partners Investissement Québec, BDC Capital, Fondaction, Fonds de solidarité FTQ, Desjardins Capital and the CRIBIQ.
i4 Capital is a deep tech venture capital firm that invests in innovative seed-stage startups. As lead investors, we take an active approach that leverages our entrepreneurial spirit and technical expertise. At i4 Capital we partner with entrepreneurs to create international growth success stories by investing our time, talent, teamwork, and treasury. Our extensive network of investors, incubators, accelerators, universities, research centers, and support organizations ensures an abundant, high quality deal flow.
Spring Lane Capital offers a new approach to faster growth for companies that deploy smaller-scale projects and equipment. With our Integrated Deployment Capital model, we partner with entrepreneurs in the energy, water, food and waste industries to help them offer their customers what they really want: Solutions, not complications.
At Front Row Ventures, we want our peers to capitalize on their potential. We want to help you launch unthinkable ventures. Our team of student investors will assist you in every step of your entrepreneurial journey. Not only do we invest $50K in our portfolio companies, we create irreplaceable value for our student startups.
Amplitude Ventures is a capital catalyst for highly innovative companies at the point of value acceleration. We work with Canada's most promising healthcare companies that share our vision of bringing groundbreaking technologies to patients. Amplitude is focused on building world-class Canadian companies in precision medicine and next-generation medical devices.
Sofinnova Investments is a healthcare investment firm committed to funding innovative products that aspire to meaningfully impact the lives of patients. We invest in both private and public equity companies. Sofinnova actively partners with entrepreneurs across all stages of company formation, we are long-term investors with extensive scientific expertise, vast industry knowledge, and a track record of helping forge the path from drug development and navigating the regulatory process to company building and IPO or M&A.